Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 39620 results
Sort by: relevance publication year
Showing results for ISSN matching 0959-8049

Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells

JOURNAL ARTICLE published January 1994 in European Journal of Cancer

Authors: M.C. Pagliacci | M. Smacchia | G. Migliorati | F. Grignani | C. Riccardi | I. Nicoletti

https://doi.org/10.1016/0959-8049(94)00262-4 Actions

Cytidine triphosphate (ctp) synthetase activity during cell cycle progression in normal and malignant t-lymphocytic cells

JOURNAL ARTICLE published January 1995 in European Journal of Cancer

Authors: A.A. van den Berg | H. van Lenthe | J.B.A. Kipp | D. de Korte | A.B.P. van Kuilenburg | A.H. van Gennip

https://doi.org/10.1016/0959-8049(94)00442-8 Actions

Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer

JOURNAL ARTICLE published August 2007 in European Journal of Cancer

Authors: Frank J.G.M. Kubben | Cornelis F.M. Sier | Lukas J.A.C. Hawinkels | Harald Tschesche | Wim van Duijn | Kim Zuidwijk | Johan J. van der Reijden | Roeland Hanemaaijer | Gerrit Griffioen | Cornelis B.H.W. Lamers | Hein W. Verspaget

https://doi.org/10.1016/j.ejca.2007.05.013 Actions

When to start cytotoxic therapy in asymptomatic patients with hormone refractory prostate cancer?

JOURNAL ARTICLE published June 2008 in European Journal of Cancer

Authors: P. Hamberg | P.C.M.S. Verhagen | R. de Wit

https://doi.org/10.1016/j.ejca.2008.04.005 Actions

MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck

JOURNAL ARTICLE published March 2011 in European Journal of Cancer

Authors: Sutima Luangdilok | Carol Box | Kevin Harrington | Peter Rhŷs-Evans | Suzanne Eccles

https://doi.org/10.1016/j.ejca.2010.10.009 Actions

Tumor antigens recognised by T lymphocytes

JOURNAL ARTICLE published September 1999 in European Journal of Cancer

Authors: Thierry Boon

https://doi.org/10.1016/s0959-8049(99)81271-4 Actions

Regression of intestinal diffuse large B cell lymphoma after treatment with vedolizumab in a patient with Crohn's disease

JOURNAL ARTICLE published November 2022 in European Journal of Cancer

Authors: Shuji Yamamoto | Takero Shindo | Hiroki Kitamoto | Takeshi Kuwada | Hiroshi Seno

https://doi.org/10.1016/j.ejca.2022.09.015 Actions

Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III–IV epithelial ovarian cancer a multicenter, randomized study

JOURNAL ARTICLE published November 2010 in European Journal of Cancer

Authors: Giorgio Bolis | Giovanna Scarfone | Francesco Raspagliesi | Giorgia Mangili | Saverio Danese | Paolo Scollo | Domenica Lo Russo | Antonella Villa | Paola Daniela Aimone | Giovanni Scambia

https://doi.org/10.1016/j.ejca.2010.06.124 Actions

Tumor deposit versus extra nodal extension: a differential evaluation of prognostic relevance

JOURNAL ARTICLE published December 2018 in European Journal of Cancer

Research funded by National Natural Science Foundation of China (81672925,31670806)

Authors: Hao Chen | Zhaoqing Tang | Fenglin Liu

https://doi.org/10.1016/j.ejca.2018.07.316 Actions

Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: Results from a large treatment observational cohort study

JOURNAL ARTICLE published May 2012 in European Journal of Cancer

Authors: Fairooz F. Kabbinavar | Patrick J. Flynn | Mark Kozloff | Mark A. Ashby | Amy Sing | Charles E. Barr | Axel Grothey

https://doi.org/10.1016/j.ejca.2012.02.052 Actions

The abdominoperineal resection itself is associated with an adverse outcome: The European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer

JOURNAL ARTICLE published May 2009 in European Journal of Cancer

Authors: Marcel den Dulk | Hein Putter | Laurence Collette | Corrie A.M. Marijnen | Joakim Folkesson | Jean-Francois Bosset | Claus Rödel | Krzysztof Bujko | Lars Påhlman | Cornelis J.H. van de Velde

https://doi.org/10.1016/j.ejca.2008.11.039 Actions

2001 Anorectal function after watch and wait-policy in rectal cancer patients

JOURNAL ARTICLE published September 2015 in European Journal of Cancer

Authors: B. Hupkens | D. Lambregts | M. Van der Sande | M. Berbée | M. Martens | M. Maas | R. Beets-Tan | G. Beets | S. Breukink

https://doi.org/10.1016/s0959-8049(16)30927-3 Actions

Gene expression predictors in breast cancer: Current status, limitations and perspectives

JOURNAL ARTICLE published December 2008 in European Journal of Cancer

Authors: C. Desmedt | E. Ruíz-García | F. André

https://doi.org/10.1016/j.ejca.2008.09.011 Actions

Combination of a CpG-oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts

JOURNAL ARTICLE published May 2004 in European Journal of Cancer

Authors: A. Balsari | M. Tortoreto | D. Besusso | G. Petrangolini | L. Sfondrini | R. Maggi | S. Ménard | G. Pratesi

https://doi.org/10.1016/j.ejca.2004.01.023 Actions

17LBA Results from an open-label, randomized, controlled Phase 3 study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic RCC

JOURNAL ARTICLE published September 2015 in European Journal of Cancer

Authors: B. Rini | A. Stenzl | R. Zdrojowy | M. Kogan | M. Shkolnik | S. Oudard | S. Weikert | S. Bracarda | S. Crabb | J. Bedke | J. Ludwig | D. Maurer | R. Mendrzyk | A. Mahr | J. Fritsche | T. Weinschenk | H. Singh | A. Kirner | C. Reinhardt | T. Eisen

https://doi.org/10.1016/s0959-8049(16)31939-6 Actions

Estimates of the lifetime costs of breast cancer treatment in Canada

JOURNAL ARTICLE published April 2000 in European Journal of Cancer

Authors: B.P. Will | J.-M. Berthelot | C. Le Petit | E.M. Tomiak | S. Verma | W.K. Evans

https://doi.org/10.1016/s0959-8049(99)00340-8 Actions

Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial

JOURNAL ARTICLE published December 2023 in European Journal of Cancer

Authors: Wen-Kuan Huang | Hung-Chih Hsu | Tsai-Sheng Yang | Chun-Wei Lu | Yi-Ru Pan | Chiao-En Wu | Wen-Hung Chung | Shuen-Iu Hung | Chun-Nan Yeh

https://doi.org/10.1016/j.ejca.2023.113286 Actions

Influence of size of a postoperative residual tumor on survival of patients with ovarian carcinoma, treated postoperatively with chemotherapy

JOURNAL ARTICLE published January 1993 in European Journal of Cancer

Authors: S. Čolaković | V. Lukić | Lj. Stamatović | J. Marinković | J. Josifovski | S. Stupar | L. Vuletić

https://doi.org/10.1016/0959-8049(93)91369-v Actions

Letter comments on EJC published article: Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2–positive breast carcinomatous meningitis

JOURNAL ARTICLE published November 2018 in European Journal of Cancer

Authors: Silvia Hofer | Stefan Aebi

https://doi.org/10.1016/j.ejca.2018.07.317 Actions

Three dimensional conformal radiotherapy in the treatment of localized prostate cancer

JOURNAL ARTICLE published September 1997 in European Journal of Cancer

Authors: H.J. Feldmann | F.B. Zimmermann | J. Breul | M. Molls

https://doi.org/10.1016/s0959-8049(97)84506-6 Actions
Feedback: support@crossref.org